Top compounds associated with response to HLA-G


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.043 0.4
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA YL54 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.03 0.4
mRNA quizartinib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.041 0.4
mRNA MI-1 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
Download CSV